Recombinant BNP on Heart and Renal Function in Acute Heart Failure
NCT ID: NCT01625403
Last Updated: 2012-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
100 participants
INTERVENTIONAL
2012-07-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Clinical heart function, LVEF, SCr, GFR and other laboratory parameters will be evaluated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
rhBNP treated
standard of care with rhBNP
rhBNP
intravenous administration of rhBNP 0.01 µg/kg/min
standard of care
standard of care
standard of care
standard of care for heart failure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rhBNP
intravenous administration of rhBNP 0.01 µg/kg/min
standard of care
standard of care for heart failure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Chest Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Fang Yuan
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fang Yuan
Role: PRINCIPAL_INVESTIGATOR
Shanghai Chest Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Fang Yuan
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHCHESTCCU01
Identifier Type: -
Identifier Source: org_study_id